CAS: 331731-18-1 - ImmunoglobulinG1, anti-(human tumor necrosis factor) (human monoclonal D2E7 heavy chain),disulfide with human monoclonal D2E7 light chain, dimer
- Synonyme:
- Adalimumab
- D 2E7
- Humira
- Unii-fys6T7F842
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Adalimumab REF: TM-T9901CAS: 331731-18-1 | 99.50% | 199,00 €~662,00 € | Fr 07 Jun 24 |
 | Adalimumab REF: 3D-FI139131CAS: 331731-18-1 | Min. 95% | 674,00 €~4.122,00 € | Mo 10 Jun 24 |
Adalimumab
CAS:331731-18-1
Adalimumab (anti-TNF-alpha) is the first fully human recombinant IgG1 monoclonal antibody that specifically targets human …
Reinheit:
99.50%
Farbe und Form:
Solid
Molekulargewicht:
148 kDa
Ref: TM-T9901
| 1mg | 199,00 € | |
| 5mg | 417,00 € | |
| 10mg | 662,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 7. Juni 2024
Adalimumab
CAS:331731-18-1
Adalimumab is a monoclonal antibody that binds to TNF-α, a proinflammatory cytokine. It is used …
Formel:
C6428H9912N1694O1987S46
Reinheit:
Min. 95%
Farbe und Form:
Colorless Powder
Molekulargewicht:
144099.37971
Ref: 3D-FI139131
| 1mg | 674,00 € | |
| 2mg | 818,00 € | |
| 5mg | 1.210,00 € | |
| 10mg | 2.144,00 € | |
| 25mg | 4.122,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 10. Juni 2024
